Literature DB >> 24453283

Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis.

S Barratt1, A Millar2.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrosing interstitial pneumonia of unknown aetiology that usually leads to respiratory failure and death within 5 years of diagnosis. Alveolar epithelial cell injury, disruption of alveolar capillary membrane integrity and abnormal vascular repair and remodelling have all been proposed as possible pathogenic mechanisms. This review summarizes our current knowledge of the abnormalities in vascular remodelling observed in IPF and highlights several of the cytokines thought to play a pathogenic role, which may ultimately prove to be future therapeutic targets.
© The Author 2014. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24453283      PMCID: PMC4071293          DOI: 10.1093/qjmed/hcu012

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  28 in total

1.  Masters of angiogenesis.

Authors:  Robert M Strieter
Journal:  Nat Med       Date:  2005-09       Impact factor: 53.440

2.  Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis.

Authors:  Christian Stockmann; Yann Kerdiles; Marc Nomaksteinsky; Alexander Weidemann; Norihiko Takeda; Andrew Doedens; Antonio X Torres-Collado; Luisa Iruela-Arispe; Victor Nizet; Randall S Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

3.  Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis.

Authors:  Masaaki Sumi; Hiroaki Satoh; Katsunori Kagohashi; Hiroichi Ishikawa; Kiyohisa Sekizawa
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

4.  Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis.

Authors:  Argyris Tzouvelekis; Vaggelis Harokopos; Triantafillos Paparountas; Nikos Oikonomou; Aristotelis Chatziioannou; George Vilaras; Evangelos Tsiambas; Andreas Karameris; Demosthenes Bouros; Vassilis Aidinis
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

5.  Autocrine VEGF signaling is required for vascular homeostasis.

Authors:  Sunyoung Lee; Tom T Chen; Chad L Barber; Maria C Jordan; Jared Murdock; Sharina Desai; Napoleone Ferrara; Andras Nagy; Kenneth P Roos; M Luisa Iruela-Arispe
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

Review 6.  Pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Nina M Patel; David J Lederer; Alain C Borczuk; Steven M Kawut
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

7.  VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.

Authors:  Laszlo Farkas; Daniela Farkas; Kjetil Ask; Antje Möller; Jack Gauldie; Peter Margetts; Mark Inman; Martin Kolb
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

8.  Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.

Authors:  Remo C Russo; Rodrigo Guabiraba; Cristiana C Garcia; Lucíola S Barcelos; Ester Roffê; Adriano L S Souza; Flávio A Amaral; Daniel Cisalpino; Geovanni D Cassali; Andrea Doni; Riccardo Bertini; Mauro M Teixeira
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-03       Impact factor: 6.914

9.  VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.

Authors:  Xue-Mei Ou; Wan-Cheng Li; Dai-Shun Liu; Yan-Ping Li; Fu-Qiang Wen; Yu-Lin Feng; Shang-Fu Zhang; Xiang-Yang Huang; Tao Wang; Ke Wang; Xun Wang; Lei Chen
Journal:  Int Immunopharmacol       Date:  2008-10-29       Impact factor: 4.932

Review 10.  Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

Authors:  Argyris Tzouvelekis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2006-05-25
View more
  20 in total

1.  Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Authors:  Christa F Gaskill; Erica J Carrier; Jonathan A Kropski; Nathaniel C Bloodworth; Swapna Menon; Robert F Foronjy; M Mark Taketo; Charles C Hong; Eric D Austin; James D West; Anna L Means; James E Loyd; W David Merryman; Anna R Hemnes; Stijn De Langhe; Timothy S Blackwell; Dwight J Klemm; Susan M Majka
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

2.  Developmental Origins of Chronic Lung Diseases. Mechanical Stretch, Micro-RNAs, and Hydrogels.

Authors:  Matthew D McGraw; Laura G Sherlock; Kolene L Bailey; Steven H Abman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-08       Impact factor: 6.914

3.  Antioxidant Activity Mediates Pirfenidone Antifibrotic Effects in Human Pulmonary Vascular Smooth Muscle Cells Exposed to Sera of Idiopathic Pulmonary Fibrosis Patients.

Authors:  Alessandro Giuseppe Fois; Anna Maria Posadino; Roberta Giordo; Annalisa Cossu; Abdelali Agouni; Nasser Moustafa Rizk; Pietro Pirina; Ciriaco Carru; Angelo Zinellu; Gianfranco Pintus
Journal:  Oxid Med Cell Longev       Date:  2018-10-21       Impact factor: 6.543

4.  Mapping cardiopulmonary dynamics within the microvasculature of the lungs using dissolved 129Xe MRI.

Authors:  Peter J Niedbalski; Elianna A Bier; Ziyi Wang; Matthew M Willmering; Bastiaan Driehuys; Zackary I Cleveland
Journal:  J Appl Physiol (1985)       Date:  2020-06-18

5.  Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.

Authors:  Donna R Newman; W Shane Sills; Katherine Hanrahan; Amanda Ziegler; Kathleen McGinnis Tidd; Elizabeth Cook; Philip L Sannes
Journal:  J Histochem Cytochem       Date:  2015-11-04       Impact factor: 2.479

Review 6.  The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.

Authors:  Gillian A Kelly-Robinson; James A Reihill; Fionnuala T Lundy; Lorcan P McGarvey; John C Lockhart; Gary J Litherland; Keith D Thornbury; S Lorraine Martin
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

7.  Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).

Authors:  Jonathan A Kropski; Bradley W Richmond; Christa F Gaskill; Robert F Foronjy; Susan M Majka
Journal:  Pulm Circ       Date:  2017-10-17       Impact factor: 3.017

8.  Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation.

Authors:  Bingdi Yan; Zhongsen Ma; Shaomin Shi; Yuxin Hu; Tiangang Ma; Gao Rong; Junling Yang
Journal:  Mol Med Rep       Date:  2017-05-03       Impact factor: 2.952

9.  Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis.

Authors:  Lynne A Murray; David M Habiel; Miriam Hohmann; Ana Camelo; Huilan Shang; Yang Zhou; Ana Lucia Coelho; Xueyan Peng; Mridu Gulati; Bruno Crestani; Matthew A Sleeman; Tomas Mustelin; Meagan W Moore; Changwan Ryu; Awo D Osafo-Addo; Jack A Elias; Chun G Lee; Buqu Hu; Jose D Herazo-Maya; Darryl A Knight; Cory M Hogaboam; Erica L Herzog
Journal:  JCI Insight       Date:  2017-08-17

10.  Balanced Wnt/Dickkopf-1 signaling by mesenchymal vascular progenitor cells in the microvascular niche maintains distal lung structure and function.

Authors:  Megan E Summers; Bradley W Richmond; Jonathan A Kropski; Sarah A Majka; Julie A Bastarache; Antonis K Hatzopoulos; Jeffery Bylund; Moumita Ghosh; Irina Petrache; Robert F Foronjy; Patrick Geraghty; Susan M Majka
Journal:  Am J Physiol Cell Physiol       Date:  2020-10-21       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.